510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K910351Substantially Equivalent

Miniclinic Ovulation Prediction Test

Vanguard Biomedical Corp., San Diego CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K910351 is the FDA 510(k) clearance record for MINICLINIC OVULATION PREDICTION TEST, a class I device, cleared for Vanguard Biomedical Corp. on under FDA product code CEP (Radioimmunoassay, Luteinizing Hormone). FDA records list 10 510(k) clearances for Vanguard Biomedical Corp., from to . As of , FDA records show no recalls naming K910351.

Clearance record

Decision date
Received
(65 days to decision)
Product code
CEP Radioimmunoassay, Luteinizing Hormone
Regulation
21 CFR 862.1485
Device class
Class I
Review panel
Clinical Chemistry
Applicant
Vanguard Biomedical Corp. 7822 Convoy Ct., San Diego CA
Third party review
No

Clearances, product code CEP

Trailing 12 months

FDA records hold no clearances under product code CEP in the trailing twelve months.

FDA records show no clearances under product code CEP in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code CEP, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260